<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="brief-report" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Hosp Med</journal-id><journal-id journal-id-type="iso-abbrev">J Hosp Med</journal-id><journal-id journal-id-type="pmc-domain-id">3654</journal-id><journal-id journal-id-type="pmc-domain">jhospmed</journal-id><journal-id journal-id-type="publisher-id">JHM</journal-id><journal-title-group><journal-title>Journal of Hospital Medicine</journal-title></journal-title-group><issn pub-type="ppub">1553-5592</issn><issn pub-type="epub">1553-5606</issn><publisher><publisher-name>Frontline Medical Communications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8626058</article-id><article-id pub-id-type="pmcid-ver">PMC8626058.1</article-id><article-id pub-id-type="pmcaid">8626058</article-id><article-id pub-id-type="pmcaiid">8626058</article-id><article-id pub-id-type="pmid">34797996</article-id><article-id pub-id-type="doi">10.12788/jhm.3721</article-id><article-id pub-id-type="publisher-id">0160724</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Brief Report</subject></subj-group></article-categories><title-group><article-title>Initiation of Long-Acting Opioids Following Hospital Discharge Among Medicare Beneficiaries</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Deshpande</surname><given-names initials="BR">Bhushan R</given-names></name><degrees>MD</degrees><xref rid="af1-0160724" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McCarthy</surname><given-names initials="EP">Ellen P</given-names></name><degrees>PhD, MPH</degrees><xref rid="af1-0160724" ref-type="aff">1</xref><xref rid="af2-0160724" ref-type="aff">2</xref><xref rid="af3-0160724" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jung</surname><given-names initials="Y">Yoojin</given-names></name><degrees>PhD, MS</degrees><xref rid="af3-0160724" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Anderson</surname><given-names initials="TS">Timothy S</given-names></name><degrees>MD, MAS</degrees><xref rid="af1-0160724" ref-type="aff">1</xref><xref rid="af3-0160724" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Herzig</surname><given-names initials="SJ">Shoshana J</given-names></name><degrees>MD, MPH</degrees><xref rid="af1-0160724" ref-type="aff">1</xref><xref rid="af3-0160724" ref-type="aff">3</xref><xref rid="cor1-0160724" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-0160724">
<label>1</label>Harvard Medical School, Boston, Massachusetts</aff><aff id="af2-0160724">
<label>2</label>Linda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts</aff><aff id="af3-0160724">
<label>3</label>Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts</aff><author-notes><corresp id="cor1-0160724"><label>*</label><bold>Corresponding Author:</bold> Shoshana J Herzig, MD, MPH; Email: <email>sherzig@bidmc.harvard.edu</email>; Telephone: 617-754-1413; Twitter: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://twitter.com/shaniherzig" ext-link-type="uri">@ShaniHerzig</ext-link>.</corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2021</year></pub-date><volume>16</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">394514</issue-id><fpage>724</fpage><lpage>726</lpage><history><date date-type="received"><day>08</day><month>10</month><year>2021</year></date><date date-type="accepted"><day>08</day><month>10</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>12</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>01</day><month>12</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2022-12-01 00:10:11.110"><day>01</day><month>12</month><year>2022</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2021 Society of Hospital Medicine</copyright-statement><copyright-year>2021</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="0160724.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="0160724.pdf"/><abstract><p>Guidelines recommend against initiating long-acting opioids during acute hospitalization, owing to higher risk of overdose and morbidity compared to short-acting opioid initiation. We investigated the incidence of long-acting opioid initiation following hospitalization in a retrospective cohort of Medicare beneficiaries with an acute care hospitalization in 2016 who were &#8805;65 years old, did not have cancer or hospice care, and had not filled an opioid prescription within the preceding 90 days. Among 258,193 hospitalizations, 47,945 (18.6%) were associated with a claim for a new opioid prescription in the week after hospital discharge: 817 (0.3%) with both short- and long-acting opioids, 125 (0.1%) with long-acting opioids only, and 47,003 (18.2%) with short-acting opioids only. Most long-acting opioid claims occurred in surgical patients (770 out of 942; 81.7%). Compared with beneficiaries prescribed short-acting opioids only, beneficiaries prescribed long-acting opioids were younger, had a higher prevalence of diseases of the musculoskeletal system and connective tissue, and had more known risk factors for opioid-related adverse events, including anxiety disorders, opioid use disorder, prior long-term high-dose opioid use, and benzodiazepine co-prescription. These findings may help target quality-improvement initiatives.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>